This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions | MicrobiomeTrials
← Back to trials NCT04549571
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2021-02-16Est. Completion: 2024-05-01
Enrollment target: 614 participantsLocations Kaiser Permanente-Vallejo, Vallejo, California, United States Helen F Graham Cancer Center, Newark, Delaware, United States Beebe Health Campus, Rehoboth Beach, Delaware, United States Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States SSM Health Good Samaritan, Mount Vernon, Illinois, United States Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States West Michigan Cancer Center, Kalamazoo, Michigan, United States Ascension Borgess Hospital, Kalamazoo, Michigan, United States Northern Westchester Hospital, Mount Kisco, New York, United States NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States Novant Health Breast Surgery - Greensboro, Greensboro, North Carolina, United States Other microbiome trials you might be interested in Advanced Malignant Solid Neoplasm Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Locally Advanced Malignant Solid Neoplasm Malignant Female Reproductive System Neoplasm Metastatic HER2-Negative Breast Carcinoma Metastatic Malignant Solid Neoplasm Recurrent Endometrial Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Malignant Female Reproductive System Neoplasm Recurrent Malignant Solid Neoplasm Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Unresectable HER2-Negative Breast Carcinoma
Sanford Bismarck Medical Center, Bismarck, North Dakota, United States
Sanford Broadway Medical Center, Fargo, North Dakota, United States
Adena Regional Medical Center, Chillicothe, Ohio, United States
Saint Ann's Hospital, Westerville, Ohio, United States
Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States
Baptist Memorial Hospital for Women, Memphis, Tennessee, United States
ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States
Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States
Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States
Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States
Aspirus Regional Cancer Center, Wausau, Wisconsin, United States
Ascension Medical Group Southeast Wisconsin - Mayfair Road, Wauwatosa, Wisconsin, United States
Aurora West Allis Medical Center, West Allis, Wisconsin, United States Unresectable Malignant Solid Neoplasm
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment…
Birmingham, United States Est. completion Jul 1, 2030
Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 HER2-Negative Breast Carcinoma Hormone Receptor-Positive Breast Carcinoma
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chem…
Birmingham, United States Est. completion May 31, 2032